Yantai Dongcheng Pharmaceutical Group Co.,Ltd.
002675.SZ · SHZ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | CN¥10,076,563 | CN¥15,117,796 | CN¥13,377,267 | CN¥12,658,937 |
| - Cash | CN¥755,972 | CN¥644,418 | CN¥1,021,624 | CN¥826,611 |
| + Debt | CN¥784,620 | CN¥792,234 | CN¥635,597 | CN¥1,049,275 |
| Enterprise Value | CN¥10,105,211 | CN¥15,265,612 | CN¥12,991,240 | CN¥12,881,601 |
| Revenue | CN¥2,868,937 | CN¥3,275,648 | CN¥3,582,955 | CN¥3,912,050 |
| % Growth | -12.4% | -8.6% | -8.4% | – |
| Gross Profit | CN¥1,347,648 | CN¥1,354,084 | CN¥1,532,273 | CN¥1,587,758 |
| % Margin | 47% | 41.3% | 42.8% | 40.6% |
| EBITDA | CN¥432,688 | CN¥511,691 | CN¥672,089 | CN¥727,923 |
| % Margin | 15.1% | 15.6% | 18.8% | 18.6% |
| Net Income | CN¥183,826 | CN¥209,736 | CN¥307,291 | CN¥151,561 |
| % Margin | 6.4% | 6.4% | 8.6% | 3.9% |
| EPS Diluted | 0.223 | 0.254 | 0.38 | 0.189 |
| % Growth | -12.4% | -33.1% | 101.2% | – |
| Operating Cash Flow | CN¥287,151 | CN¥276,945 | CN¥996,537 | CN¥943,581 |
| Capital Expenditures | -CN¥456,094 | -CN¥511,945 | -CN¥389,612 | -CN¥530,158 |
| Free Cash Flow | -CN¥168,943 | -CN¥235,001 | CN¥606,925 | CN¥413,424 |